Question

I am a breastfeeding mother and i want to know if it is safe to use UNII-3QN8BYN5QF? Is UNII-3QN8BYN5QF safe for nursing mother and child? Does UNII-3QN8BYN5QF extracts into breast milk? Does UNII-3QN8BYN5QF has any long term or short term side effects on infants? Can UNII-3QN8BYN5QF influence milk supply or can UNII-3QN8BYN5QF decrease milk supply in lactating mothers?

UNII-3QN8BYN5QF lactation summary

UNII-3QN8BYN5QF is unsafe in breastfeeding
  • DrLact safety Score for UNII-3QN8BYN5QF is 5 out of 8 which is considered Unsafe as per our analyses.
  • A safety Score of 5 indicates that usage of UNII-3QN8BYN5QF may cause serious side effects in breastfed baby.
  • Our study of different scientific research indicates that UNII-3QN8BYN5QF may cause moderate to high side effects or may affect milk supply in lactating mother.
  • Our suggestion is to use safer alternate options rather than using UNII-3QN8BYN5QF .
  • It is recommended to evaluate the advantage of not breastfeeding while using UNII-3QN8BYN5QF Vs not using UNII-3QN8BYN5QF And continue breastfeeding.
  • While using UNII-3QN8BYN5QF Its must to monitor child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About UNII-3QN8BYN5QF usage in lactation

Immunomodulator agent indicated for the treatment of patients affected with very active type of RRMS. At latest update no published data on excretion into breast milk were found.Pharmacokinetic data (large volume of distribution and high protein binding capacity) make it unlikely its passage to breast milk in significant amounts. Its slow elimination rate with a half-life span between 6 and 9 days and its potentially serious cardiac effects suggest that a safer alternative should be preferred until more published data on this drug in relation to breastfeeding is available, especially during the neonatal period and in case prematurity.

Answer by DrLact: About UNII-3QN8BYN5QF usage in lactation

Because there is no published experience with UNII-3QN8BYN5QF during breastfeeding, it should be avoided during breastfeeding, especially while nursing a newborn or preterm infant.[1][2][3][4[
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.